CARE_CUBE_SOLUTIONS_LTD - Accounts


Company registration number 09653823 (England and Wales)
CARE CUBE SOLUTIONS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022
PAGES FOR FILING WITH REGISTRAR
Sherlock & Co Limited
Chartered Accountants
CARE CUBE SOLUTIONS LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
CARE CUBE SOLUTIONS LTD
BALANCE SHEET
AS AT 30 SEPTEMBER 2022
30 September 2022
- 1 -
2022
2021
as restated
Notes
£
£
£
£
Fixed assets
Intangible assets
3
155,330
177,520
Tangible assets
4
1,232
2,427
156,562
179,947
Current assets
Debtors
5
421,763
38,124
Cash at bank and in hand
8,549
36,245
430,312
74,369
Creditors: amounts falling due within one year
6
(263,362)
(278,701)
Net current assets/(liabilities)
166,950
(204,332)
Total assets less current liabilities
323,512
(24,385)
Creditors: amounts falling due after more than one year
7
(355,369)
(27,867)
Net liabilities
(31,857)
(52,252)
Capital and reserves
Called up share capital
1,287
1,240
Share premium account
792,328
690,575
Profit and loss reserves
(825,472)
(744,067)
Total equity
(31,857)
(52,252)
CARE CUBE SOLUTIONS LTD
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2022
30 September 2022
- 2 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 December 2022 and are signed on its behalf by:
T Coutts
Director
Company Registration No. 09653823
CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 3 -
1
Accounting policies
Company information

Care Cube Solutions Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Ebenezer House, Ryecroft, Newcastle-Under-Lyme, Staffordshire, ST5 2BE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

1.2
Going concern

After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being the 12 month period from the date of these accounts being approved, given the impact of the Coronavirus upon the economy, and therefore the financial statements have been prepared on a going concern basis.

1.3
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

1.4
Research and development expenditure

Development costs are capitalised where the following conditions apply:

 

- There is a clearly defined project.

- The related expenditure is separately identifiable.

- The outcome of the project has been assessed with reasonable certainty as to its technical feasibility and its ultimate commercial viability.

- Total research and development costs on the project are expected to be exceeded by related future revenues.

- Adequate resources are reasonably expected to be available to enable the project to be completed.

 

Capitalised development costs are included as "Development costs" under Intangible Fixed Assets.

 

Development Costs are amortised commencing with the commercial application of the related project and are allocated on a systematic basis to each accounting period by reference to the expected useful economic life of the project.

 

Other research and development costs are written off to the profit and loss account in the year in which they are incurred, regardless of whether they satisfy the above conditions or not.

1.5
Intangible fixed assets other than goodwill

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs
over 10 years
CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
1
Accounting policies
(Continued)
- 4 -
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computers
33% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Where a reasonable and consistent basis of allocation can be identified, assets are allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax

Current or deferred taxation assets and liabilities are not discounted.

 

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

 

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

 

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

1.11
Retirement benefits

The company operated a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

1.12
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
1
Accounting policies
(Continued)
- 6 -

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
7
5
3
Intangible fixed assets
Other
£
Cost
At 1 October 2021 and 30 September 2022
221,899
Amortisation and impairment
At 1 October 2021
44,379
Amortisation charged for the year
22,190
At 30 September 2022
66,569
Carrying amount
At 30 September 2022
155,330
At 30 September 2021
177,520
CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 7 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2021 and 30 September 2022
6,090
Depreciation and impairment
At 1 October 2021
3,663
Depreciation charged in the year
1,195
At 30 September 2022
4,858
Carrying amount
At 30 September 2022
1,232
At 30 September 2021
2,427
5
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
249,378
-
0
Corporation tax recoverable
70,382
38,124
Other debtors
3,814
-
0
323,574
38,124
2022
2021
Amounts falling due after more than one year:
£
£
Deferred tax asset
98,189
-
0
Total debtors
421,763
38,124
6
Creditors: amounts falling due within one year
2022
2021
£
£
Bank loans
43,314
7,600
Trade creditors
4,469
23,553
Taxation and social security
67,552
61,380
Other creditors
148,027
186,168
263,362
278,701
CARE CUBE SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2022
- 8 -
7
Creditors: amounts falling due after more than one year
2022
2021
£
£
Bank loans and overdrafts
103,600
27,867
Other creditors
251,769
-
0
355,369
27,867

The long-term loan is secured by a first ranking all assets debenture, postponement of director/shareholder loan repayments and legal assignment over key-person assurance policies.

8
Prior period adjustment
Reconciliation of changes in equity
1 October
30 September
2020
2021
£
£
Adjustments to prior year
Amortisation of Development Costs
-
(44,379)
Equity as previously reported
-
(7,873)
Equity as adjusted
-
(52,252)
Analysis of the effect upon equity
Profit and loss reserves
-
(44,379)
Reconciliation of changes in loss for the previous financial period
2021
£
Adjustments to prior year
Amortisation of Development Costs
(44,379)
Loss as previously reported
(188,226)
Loss as adjusted
(232,605)
Notes to reconciliation

Development costs which have been capitalised within intangible fixed assets were not depreciated from the date that the development was completed, which was in October 2019. The above prior period adjustment, therefore, has restated the accounts to include depreciation which should have been applied.

2022-09-302021-10-01false08 December 2022CCH SoftwareCCH Accounts Production 2022.300No description of principal activityR NodenT CouttsR Gamlin096538232021-10-012022-09-30096538232022-09-30096538232021-09-3009653823core:IntangibleAssetsOtherThanGoodwill2022-09-3009653823core:IntangibleAssetsOtherThanGoodwill2021-09-3009653823core:OtherPropertyPlantEquipment2022-09-3009653823core:OtherPropertyPlantEquipment2021-09-3009653823core:CurrentFinancialInstrumentscore:WithinOneYear2022-09-3009653823core:CurrentFinancialInstrumentscore:WithinOneYear2021-09-3009653823core:Non-currentFinancialInstrumentscore:AfterOneYear2022-09-3009653823core:Non-currentFinancialInstrumentscore:AfterOneYear2021-09-3009653823core:CurrentFinancialInstruments2022-09-3009653823core:CurrentFinancialInstruments2021-09-3009653823core:Non-currentFinancialInstruments2022-09-3009653823core:Non-currentFinancialInstruments2021-09-3009653823core:ShareCapital2022-09-3009653823core:ShareCapital2021-09-3009653823core:SharePremium2022-09-3009653823core:SharePremium2021-09-3009653823core:RetainedEarningsAccumulatedLosses2022-09-3009653823core:RetainedEarningsAccumulatedLosses2021-09-3009653823bus:Director22021-10-012022-09-3009653823core:IntangibleAssetsOtherThanGoodwill2021-10-012022-09-3009653823core:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-10-012022-09-3009653823core:ComputerEquipment2021-10-012022-09-30096538232020-10-012021-09-3009653823core:IntangibleAssetsOtherThanGoodwill2021-09-3009653823core:OtherPropertyPlantEquipment2021-09-3009653823core:OtherPropertyPlantEquipment2021-10-012022-09-3009653823core:WithinOneYear2022-09-3009653823core:WithinOneYear2021-09-3009653823core:AfterOneYear2022-09-3009653823core:AfterOneYear2021-09-3009653823bus:PrivateLimitedCompanyLtd2021-10-012022-09-3009653823bus:SmallCompaniesRegimeForAccounts2021-10-012022-09-3009653823bus:FRS1022021-10-012022-09-3009653823bus:AuditExemptWithAccountantsReport2021-10-012022-09-3009653823bus:Director12021-10-012022-09-3009653823bus:Director32021-10-012022-09-3009653823bus:FullAccounts2021-10-012022-09-30xbrli:purexbrli:sharesiso4217:GBP